l9n/ Pennsylvania

2021–2022 Regular Session

House Bill 1033

An Act providing for patient access to diagnostics and treatments for Lyme disease and related tick-borne illnesses; and requiring health care policies to provide certain coverage.

Did not become law. It stopped in the Senate's Banking & Insurance Committee on June 7, 2021. The 2021–2022 session has ended.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

Its course

March 26 to June 7, 2021, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action13 actions on 5 days

In the House of RepresentativesMar 26 to Jun 773 days

HealthMar 26 to May 540 days

AppropriationsMay 26 to Jun 712 days

In the SenateJun 7 to Jun 7 · stopped0 days

Banking & InsuranceJun 7 to Jun 7 · stopped0 days

Votes

Yeas to nays, as the General Assembly recorded them. Committee votes are set in.

  • House of Representatives, third reading136–66

    Passed · Jun 7

Text

Each version as the General Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the General Assembly published it is below.

In the House of Representatives Mar 26 – Jun 7

  1. Sent to HEALTH
  2. HEALTH recommended it
  3. Read a second time
  4. Sent to APPROPRIATIONS
  5. APPROPRIATIONS recommended it
  6. Passed the House of Representatives, 136 to 66

In the Senate Jun 7

  1. Arrived in the Senate
  2. Sent to BANKING AND INSURANCE
All 13 actions, as published